Advertisement
ANSLF vs MASI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANSLF is a Buy and MASI is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ANSLF’s FA Score shows that 1 FA rating(s) are green whileMASI’s FA Score has 1 green FA rating(s).
- ANSLF’s FA Score: 1 green, 4 red.
- MASI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ANSLF’s TA Score shows that 2 TA indicator(s) are bullish while MASI’s TA Score has 7 bullish TA indicator(s).
- ANSLF’s TA Score: 2 bullish, 3 bearish.
- MASI’s TA Score: 7 bullish, 2 bearish.
Price Growth
ANSLF (@Pharmaceuticals: Other) experienced а +0.23% price change this week, while MASI (@Medical/Nursing Services) price change was +5.38% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.62%. For the same industry, the average monthly price growth was +0.12%, and the average quarterly price growth was +6.19%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.41%. For the same industry, the average monthly price growth was -4.56%, and the average quarterly price growth was +6.50%.
Reported Earning Dates
MASI is expected to report earnings on Mar 03, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+1.62% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+0.41% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ANSLF | MASI | ANSLF / MASI | |
| Capitalization | 3.46B | 8.05B | 43% |
| EBITDA | 260M | -115.8M | -225% |
| Gain YTD | 1.644 | -9.383 | -18% |
| P/E Ratio | 34.25 | 116.80 | 29% |
| Revenue | 2B | 2.15B | 93% |
| Total Cash | 238M | 150M | 159% |
| Total Debt | 806M | 642M | 126% |
ANSLF | MASI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 48 | 10 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 19 Undervalued | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 90 | 96 | |
PRICE GROWTH RATING 1..100 | 46 | 60 | |
P/E GROWTH RATING 1..100 | 47 | 13 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ANSLF's Valuation (19) in the null industry is significantly better than the same rating for MASI (91) in the Medical Specialties industry. This means that ANSLF’s stock grew significantly faster than MASI’s over the last 12 months.
ANSLF's Profit vs Risk Rating (100) in the null industry is in the same range as MASI (100) in the Medical Specialties industry. This means that ANSLF’s stock grew similarly to MASI’s over the last 12 months.
ANSLF's SMR Rating (90) in the null industry is in the same range as MASI (96) in the Medical Specialties industry. This means that ANSLF’s stock grew similarly to MASI’s over the last 12 months.
ANSLF's Price Growth Rating (46) in the null industry is in the same range as MASI (60) in the Medical Specialties industry. This means that ANSLF’s stock grew similarly to MASI’s over the last 12 months.
MASI's P/E Growth Rating (13) in the Medical Specialties industry is somewhat better than the same rating for ANSLF (47) in the null industry. This means that MASI’s stock grew somewhat faster than ANSLF’s over the last 12 months.
| ANSLF | MASI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 45% | N/A |
| Stochastic ODDS (%) | 2 days ago 32% | 2 days ago 67% |
| Momentum ODDS (%) | N/A | 2 days ago 65% |
| MACD ODDS (%) | N/A | 2 days ago 69% |
| TrendWeek ODDS (%) | 2 days ago 26% | 2 days ago 68% |
| TrendMonth ODDS (%) | 2 days ago 21% | 2 days ago 67% |
| Advances ODDS (%) | N/A | 2 days ago 66% |
| Declines ODDS (%) | N/A | 28 days ago 67% |
| BollingerBands ODDS (%) | N/A | 2 days ago 66% |
| Aroon ODDS (%) | 2 days ago 15% | 4 days ago 76% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GSMAX | 21.30 | 0.09 | +0.42% |
| Goldman Sachs Small/Mid Cap Growth A | |||
| VSPMX | 442.27 | 1.53 | +0.35% |
| Vanguard S&P Mid-Cap 400 Index I | |||
| DNLCX | 54.82 | 0.12 | +0.22% |
| BNY Mellon Active MidCap C | |||
| FBONX | 39.56 | 0.07 | +0.18% |
| American Funds American Balanced 529-F-3 | |||
| MCGAX | 10.46 | -0.01 | -0.10% |
| Transamerica Mid Cap Growth A | |||
ANSLF and
Correlation & Price change
A.I.dvisor indicates that over the last year, ANSLF has been loosely correlated with PXMBF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ANSLF jumps, then PXMBF could also see price increases.
| Ticker / NAME | Correlation To ANSLF | 1D Price Change % | ||
|---|---|---|---|---|
| ANSLF | 100% | N/A | ||
| PXMBF - ANSLF | 37% Loosely correlated | N/A | ||
| MASI - ANSLF | 22% Poorly correlated | +2.12% | ||
| CNTGF - ANSLF | 21% Poorly correlated | N/A | ||
| AMBBY - ANSLF | 11% Poorly correlated | N/A | ||
| BBLG - ANSLF | 3% Poorly correlated | +2.31% | ||
More | ||||
MASI and
Correlation & Price change
A.I.dvisor indicates that over the last year, MASI has been loosely correlated with SYK. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MASI jumps, then SYK could also see price increases.
| Ticker / NAME | Correlation To MASI | 1D Price Change % | ||
|---|---|---|---|---|
| MASI | 100% | +2.12% | ||
| SYK - MASI | 49% Loosely correlated | +1.00% | ||
| VCYT - MASI | 47% Loosely correlated | -0.84% | ||
| ISRG - MASI | 46% Loosely correlated | +0.05% | ||
| KIDS - MASI | 46% Loosely correlated | -1.28% | ||
| ENOV - MASI | 45% Loosely correlated | -0.86% | ||
More | ||||